• Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology clinical trials market
• Genesis Capital is partnering with existing management to expand Crux into new testing and clinical trial streams

MELBOURNE,...